FORTREA HOLDINGS INC.

NASDAQ: FTRE (Fortrea Holdings Inc.)

Last update: 25 Jun, 1:30AM

5.31

0.21 (4.12%)

Previous Close 5.10
Open 5.26
Volume 1,896,178
Avg. Volume (3M) 2,962,593
Market Cap 480,769,024
Price / Earnings (Forward) 29.41
Price / Sales 0.170
Price / Book 0.550
52 Weeks Range
3.97 (-25%) — 28.41 (435%)
Earnings Date 11 Aug 2025 - 15 Aug 2025
Profit Margin -29.43%
Operating Margin (TTM) -3.81%
Diluted EPS (TTM) -8.39
Quarterly Revenue Growth (YOY) -1.60%
Total Debt/Equity (MRQ) 149.92%
Current Ratio (MRQ) 0.970
Operating Cash Flow (TTM) 164.20 M
Levered Free Cash Flow (TTM) 310.66 M
Return on Assets (TTM) -1.74%
Return on Equity (TTM) -61.58%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Bearish Bearish
Biotechnology (Global) Bearish Bearish
Stock Fortrea Holdings Inc. Mixed Bearish

AIStockmoo Score

0.4
Analyst Consensus -4.5
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages 3.5
Technical Oscillators 2.0
Average 0.38

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
FTRE 481 M - - 0.550
CGON 2 B - - 2.81
CVAC 1 B - 5.81 1.62
REPL 861 M - - 1.74
VIR 731 M - - 0.720
ZVRA 616 M - - 12.54

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Sector Healthcare
Industry Biotechnology
Investment Style Small Value
% Held by Insiders 0.40%
% Held by Institutions 101.90%

Ownership

Name Date Shares Held
Beck Mack & Oliver Llc 31 Mar 2025 2,935,111
52 Weeks Range
3.97 (-25%) — 28.41 (435%)
Price Target Range
5.00 (-5%) — 8.00 (50%)
High 8.00 (Mizuho, 50.66%) Hold
Median 5.00 (-5.84%)
Low 5.00 (Evercore ISI Group, -5.84%) Hold
5.00 (Goldman Sachs, -5.84%) Hold
5.00 (Barclays, -5.84%) Sell
Average 5.75 (8.29%)
Total 3 Hold, 1 Sell
Avg. Price @ Call 4.95
Firm Date Target Price Call Price @ Call
Evercore ISI Group 09 Jul 2025 5.00 (-5.84%) Hold 5.22
Goldman Sachs 14 May 2025 5.00 (-5.84%) Hold 4.78
Mizuho 14 May 2025 8.00 (50.66%) Hold 4.78
Barclays 13 May 2025 5.00 (-5.84%) Sell 5.00

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria